Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


R&D Directions Insider

Archive for January, 2010

Quintiles stakes out “new health” territory

Tuesday, January 26th, 2010

Quintiles, the huge biopharmaceutical services company, made the announcement that it has shifted its positioning and brand identity to something called "Navigating the New Health." There's even a new logo (look left). The rounded "Q" seems to imply the full circle of services that Quintiles provides (at least, that is ...

Posted in Uncategorized | 1 Comment »

Q&A: Steve Paul

Monday, January 25th, 2010

The interview appears here, as part of our annual January Top 10 Pipelines coverage.

Posted in Uncategorized | No Comments »

Charles River’s preclinical site suspension to cost 300 jobs

Monday, January 11th, 2010

Charles River Laboratories International Inc. has provided additional details regarding today’s announcement that the company is suspending operations at its Shrewsbury, Mass., preclinical facility in the middle of the year. According to the world’s third-ranked publicly traded CRO, 300 people will be laid off as a result of the move. ...

Posted in CRO | 1 Comment »

Closer peek at Novartis-Alcon potential

Wednesday, January 6th, 2010

Not surprisingly, moods are turning a tad testy in Novartis’ bid to gain full control of Swiss neighbor Alcon Inc. (see reports here and here). But talk of “coercive’’ tactics, minority shareholder protection, and independent director committees aside, just how visionary the potential eye-care deal really is appears a bit ...

Posted in Uncategorized | No Comments »

   
about us | advertise | contact us | home
terms of use | privacy | copyright | site map 		©2013 UBM Canon